| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 371,5 k € | |||||||||||||||||||
| Gross margin | 184,8 k € | +13.6% | 162,7 k € | +5.8% | 153,8 k € | +16.9% | 131,5 k € | -12.9% | 151,0 k € | +7.4% | 140,5 k € | +4.4% | 134,6 k € | +17.6% | 114,5 k € | +12.9% | 101,3 k € | -11.8% | 114,9 k € | -31.0% | 166,5 k € | +6.2% | 156,8 k € | +7.9% | 145,3 k € | +13.9% | 127,7 k € | -15.0% | 150,2 k € | -11.4% | 169,4 k € | +2.8% | 164,8 k € | +12.4% | 146,6 k € | -8.1% | 159,5 k € | |
| EBITDA | 182,8 k € | +13.9% | 160,6 k € | +5.7% | 151,9 k € | +17.2% | 129,6 k € | -13.1% | 149,1 k € | +7.6% | 138,6 k € | +6.2% | 130,6 k € | +16.9% | 111,7 k € | +11.9% | 99,8 k € | -11.8% | 113,1 k € | -31.4% | 164,8 k € | +6.6% | 154,6 k € | +7.8% | 143,4 k € | +14.0% | 125,7 k € | -14.9% | 147,8 k € | -11.3% | 166,7 k € | +3.0% | 161,8 k € | +14.9% | 140,8 k € | -9.9% | 156,3 k € | |
| Operating profit | 179,8 k € | +14.4% | 157,1 k € | +12.8% | 139,2 k € | +19.1% | 117,0 k € | -11.5% | 132,1 k € | +8.7% | 121,6 k € | +14.0% | 106,6 k € | +10.0% | 96,9 k € | +12.8% | 86,0 k € | -17.2% | 103,8 k € | -31.1% | 150,7 k € | +7.4% | 140,3 k € | +4.7% | 133,9 k € | +28.1% | 104,6 k € | -17.7% | 127,0 k € | -13.2% | 146,4 k € | +3.2% | 141,8 k € | +17.9% | 120,2 k € | -19.0% | 148,4 k € | |
| Profit/loss | 122,1 k € | +15.3% | 105,9 k € | +14.9% | 92,2 k € | +19.3% | 77,3 k € | -12.8% | 88,6 k € | +15.2% | 76,9 k € | +15.5% | 66,6 k € | -8.5% | 72,8 k € | +13.3% | 64,2 k € | -5.1% | 67,7 k € | -46.8% | 127,3 k € | -5.3% | 134,3 k € | +1.8% | 132,0 k € | +33.6% | 98,8 k € | +14232.3% | -699,1 € | -100.9% | 78,9 k € | -18.5% | 96,7 k € | +2.7% | 94,2 k € | -30.4% | 135,4 k € | |
| Equity | 1,2 M € | +11.0% | 1,1 M € | +10.5% | 1,0 M € | +10.1% | 915,8 k € | +9.2% | 838,5 k € | +11.8% | 749,9 k € | +11.4% | 673,0 k € | -64.9% | 1,9 M € | +3.9% | 1,8 M € | +3.6% | 1,8 M € | +3.9% | 1,7 M € | +8.0% | 1,6 M € | -0.7% | 1,6 M € | +9.0% | 1,5 M € | +7.2% | 1,4 M € | -0.1% | 1,4 M € | +5.9% | 1,3 M € | +8.1% | 1,2 M € | +8.5% | 1,1 M € | |
| Total assets | 1,4 M € | +9.7% | 1,3 M € | +8.0% | 1,2 M € | +8.6% | 1,1 M € | +7.5% | 1,0 M € | +9.8% | 924,8 k € | -52.0% | 1,9 M € | -1.3% | 2,0 M € | +4.4% | 1,9 M € | +3.1% | 1,8 M € | +2.8% | 1,8 M € | +9.1% | 1,6 M € | -1.5% | 1,6 M € | +11.0% | 1,5 M € | +0.7% | 1,5 M € | -3.0% | 1,5 M € | +12.1% | 1,4 M € | +7.2% | 1,3 M € | +9.4% | 1,2 M € | |
| Cash | 943,3 k € | +15.4% | 817,7 k € | +13.7% | 719,0 k € | +17.7% | 611,0 k € | +16.3% | 525,5 k € | +34.4% | 391,0 k € | +25.1% | 312,5 k € | -0.6% | 314,5 k € | +41.8% | 221,8 k € | +17.7% | 188,4 k € | -24.1% | 248,1 k € | -68.5% | 788,3 k € | -21.6% | 1,0 M € | +167.1% | 376,6 k € | -3.7% | 391,1 k € | -8.8% | 429,0 k € | +30.5% | 328,7 k € | -33.8% | 496,8 k € | +19.8% | 414,7 k € | |
| Debts | 169,0 k € | +1.5% | 166,5 k € | -6.5% | 178,1 k € | +1.2% | 176,1 k € | -0.4% | 176,8 k € | +1.1% | 174,9 k € | -86.1% | 1,3 M € | +3623.7% | 33,7 k € | +38.2% | 24,4 k € | -25.3% | 32,6 k € | -35.3% | 50,5 k € | +68.8% | 29,9 k € | -30.4% | 42,9 k € | +82299.6% | 52,1 € | -99.9% | 73,5 k € | -47.0% | 138,6 k € | +1003.2% | 12,6 k € | -3.1% | 13,0 k € | +30.7% | 9,9 k € | |
Private company with limited liability · Linter · incorporated on 19/05/1990
Private company with limited liability profitable and well capitalised. Cash position rising (+15.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. MORREELS MARC is a Private company with limited liability incorporated in 1990. Its main activity is: General medical practice activities. Its registered office is in Linter.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette